Adding an international twist to the year's biggest patent story, Myriad has surrendered its BRCA patents in Australia, reports Genomics Law Report's Dan Vorhaus and John Conley. Several months ago, a group of plaintiffs in Australia filed a lawsuit against Myriad similar to the one filed in the US, arguing that the patents are invalid because genes can't be patented.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.